Testimony to Congress Warns of Antibiotics Overuse in Agriculture
An expert from the Union of Concerned Scientists says the overuse of antibiotics in agriculture — just as in human medicine — is undercutting the efficacy of important human therapies and generating more virulent pathogens.
July 21, 2009
From the Union of Concerned Scientists
 |
Food animal production uses the lion’s share of the antibiotics in the United States — some 13 million pounds of antibiotics every year, which is about 70 percent of the nation’s total antibiotics use.
FOXYPAR4/FLICKR
|
On July 13, the Union of Concerned Scientists’ Margaret Mellon testified before the House Rules Committee in a hearing on H.R. 1549, the Preservation of Antibiotics for Medical Treatment Act (PAMTA).
RELATED CONTENT
Learn all about H1N1 (swine flu) and the seasonal flu viruses, including how H1N1 developed, how fl...
Wound Treatment Basics
December/January 2000
Wound Treatment Basics
1. Control hemorrhage w...
Keeping sheep and goats safe from predators can be a headache, but many farmers have found a natura...
TAKING ON LIVESTOCK, PART I March/April 1987 MOTHER'S HANDBOOK How to choose the right food-produci...
TUBERCULOSIS IN LIVESTOCK December/January 1992 COUNTRY VET A nearly extinct disease is back By Dr....
Mellon explained the scientific case connecting antibiotic resistance with the practice of feeding antibiotics to livestock and poultry that are not sick. This is of particular concern as Congress considers measures to increase food safety, as the bacteria most commonly associated with food-borne illnesses are also likely to resist drug treatment.
Mellon also offered detailed analysis confirming that swift congressional action on PAMTA is the only way to keep antibiotics working and to protect the food supply and our health.
Read Mellon’s full testimony for more information.
The Union of Concerned Scientists is the leading science-based nonprofit organization working for a healthy environment and a safer world. Founded in 1969, UCS is headquartered in Cambridge, Mass., and has offices in Berkeley, Calif., Chicago and Washington, D.C.